期刊文献+

鞘氨醇激酶1和核因子κB p65在结肠癌中的表达及其临床意义 被引量:8

The expression and clinical significance of SphK1 and nuclear factor-κB p65 in human coloncarcinoma
原文传递
导出
摘要 目的探讨鞘氨醇激酶1(SphKl)和NF-κB在结肠癌组织中的表达及其临床意义。方法采用免疫组化sP法、Western blot法和半定量RT-PCR法,检测66例结肠癌、癌旁及正常结肠黏膜组织中SpbKl和NF-κB的蛋白及mRNA表达。结果RT-PCR结果显示,66例结肠癌组织中SphKl和NF-κBmRNA阳性表达率分别为84.85%(56/66)和74.24%(49/66),Westernblot结果显示其SphKl和NF-κB蛋白阳性表达率分别为78.79%(52/66)和69.70%(46/66),均高于癌旁[mRNA:63.64%(42/66),48.49%(32/66);蛋白:57.58%(38/66),45.45%(30/66)]和正常黏膜组织[mRNA:42.42%(28/66),25.76%(17/66);蛋白:36.36%(24/66),24.24%(16/66)],P值均〈0.05。结肠癌组织中SphKl和NF-κB的mRNA及蛋白的相对表达水平均高于癌旁及正常结肠黏膜组织(mRNA:0.554-0.06比0.354-0.05比0.25±0.05,0.75±0.06比0.434-0.05比0.304-0.04:蛋白:0.774-0.05比0.384-0.06比0.124-0.03,0.454-0.08比0.23±0.05比0.134-0.03;p值均〈0.05)。SphKl和NF-κB表达之间存在明显相关性(r=0.459,P=0.036)。免疫组化结果与前述较为一致。SphKl和NF-κB在癌组织中的高表达水平与肿瘤浸润程度、有无远处转移、淋巴结转移、临床分期有关(P值均〈0.05)。SphKl的高表达水平还与组织分化程度有关(P〈0.05)。结论SphKl和NF-κB可能与结肠癌的发生、发展密切相关,并可能在结肠癌的浸润和转移中起重要作用。 Objective To investigate the expression of sphingosine kinase 1 ( SphK1 ) and NF-κB in colon carcinoma tissues and their correlation with clinicopathologic features. Methods Sixty-six paraffin- embedded colon carcinoma samples and 66 fresh colon carcinoma samples were tested using immunohistoehemistry, RT-PCR and Western blot, respectively. Results In 66 fresh colon carcinoma samples, the positive rate of SphK1 and NF-κB mRNA expression were 84. 85% (56/66) and 74. 24% (49/66) , while the positive rate of SphK1 and NF-κB protein detected by Western blot were 78.79% (52/66) and 69. 70% (46/66). The positive rates were higher than those in the adjacent tissues [ mRNA: 63.64% (42/66) ,48.49% (32/66) ;protein:57.58% (38/66) ,45.45% (30/66) ] and the normal mucosa [ mRNA:42. 42% ( 28/66 ), 25.76% ( 17/66 ) ; protein: 36. 36% ( 24/66 ), 24. 24% ( 16/66 ) ], with statistical significances ( all P values 〈 0. 05 ). The mean expressive levels of SphK1 and NF-κB mRNA and protein in colon carcinoma were both significantly higher than those in the adjacent tissues and the normal mucosa (mRNA: 0.55±0.06 vs0.35 ±0.05 vs0.25±0.05, 0.75±0.06 vs0.43±0.05 vsO. 30± 0.04; protein: 0.77±0.05 vs0.38±0.06vsO. 12±0.03, 0.45±0.08 vs0.23±0.05 vs0.13±0.03; all P values 〈 0. 05 ). There was a close correlation between SphK1 and NF-κB expression levels ( r = 0. 459, P = 0. 036). The results of immunohistochemistry were similar to those of RT-PCR and Western blot. Overexpression of SphK1 and NF-κB in colon carcinoma was related with depth of invasion, distant and lymph node metastasis and Dukes'stages (all P values 〈 0. 05). The expression of SphK1 was also relatedwith differentiation (P 〈 0. 05). Conclusions Overexpression of SphK1 and NF-κB may be involved in the pathogenesis and progression of colon carcinoma. Moreover, SphK1 and NF-κB may be correlated with the invasion and metastasis of colon carcinoma.
出处 《中华内科杂志》 CAS CSCD 北大核心 2012年第3期220-224,共5页 Chinese Journal of Internal Medicine
基金 国家自然科学基金(30760275) 广西壮族自治区卫生厅基金(Z2008107)
关键词 结肠肿瘤 肿瘤转移 NF-ΚB 鞘氨醇激酶1 Colonic neoplasms Neoplasm metastasis NF-kappa B Sphingosine kinase 1
  • 相关文献

参考文献15

  • 1Bergelin N,Blom T,Heikkila J,et al.Sphingosine kinase as an oncogene:autocrine sphingosine 1-phosphate modulates ML-1thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-alpha and ERK1/2.Endocrinology,2009,150:2055-2063.
  • 2Li W,Yu CP,Xia JT,et al.Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients.Clin Cancer Res,2009,15:1393-1399.
  • 3Puvvada SD,Funkhouser WK,Greene K,et al.NF-kB and Bcl-3 activation are prognostic in metastatic colorectal cancer.Oncology,2010,78:181-188.
  • 4刘诗权,覃蒙斌,黄杰安,钟月圆,唐国都,姜海行.鞘氨醇激酶1调控p38和c—Jun氨基末端激酶通路影响结肠癌HT-29细胞的凋亡迁移与侵袭[J].中华肿瘤杂志,2011,33(3):178-182. 被引量:6
  • 5钟月圆,黄杰安,刘诗权,覃蒙斌,金卉.Sphk1对人结肠癌细胞株Lovo增殖与侵袭的影响及其作用机制[J].世界华人消化杂志,2010,18(24):2528-2532. 被引量:6
  • 6Alemany R,Perona JS,Sánchez-Dominguez JM,et al.G proteincoupled receptor systems and their lipid environment in health disorders during aging.Biochim Biophys Acta,2007,1768:964-975.
  • 7Hait NC,Oskeritzian CA,Paugh SW,et al.Sphingosine kinases,sphingosine 1-phosphate,apoptosis and diseases.Biochim Biophys Acta,2006,1758:2016-2026.
  • 8Taha TA,Mullen TD,Obeid LM.A house divided:ceramide,sphingosine,and sphingosine-l-phosphate in programmed cell death.Biochim Biophys Acta,2006,1758:2027-2036.
  • 9Kawamori T,Osta W,Johnson KR,et al.Sphingosine kinase 1 is up-regulated in colon carcinogenesis.FASEB J,2006,20:386-388.
  • 10Xia P,Gamble JR,Wang L,et al.An oncogenic role of sphingosine kinase.Curr Biol,2000,10:1527-1530.

二级参考文献29

  • 1Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol 2003; 4:397-407.
  • 2French KJ, Schrecengost RS, Lee BD, Zhuang Y, Smith SN, Eberly JL, Yun JK, Smith CD. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 2003; 63:5962-5969.
  • 3Cuvillier O. Sphingosine kinase-1-a potential therapeutic target in cancer. Anticancer Drugs 2007; 18: 105-110.
  • 4Hengst JA, Guilford JM, Fox TE, Wang X, Conroy EJ, Yun JK. Sphingosine kinase 1 localized to the plasma membrane lipid raft microdomain overcomes serum deprivation induced growth inhibition. Arch Biochem Biophys 2009; 492:62-73.
  • 5Koda M, Mutate T, Wang S, Ohguchi K, Sobue S, Ikeda M, Tamiya-Koizumi K, Igarashi Y, Nozawa Y, Banno Y. Sphingosine kinase 1 is involved in dibutyryl cyclic AMP-induced granulocytic differentiation through the upregulation of extracellular signal-regulated kinase, but not p38 MAP kinase, in HL60 cells. Biochim Biophys Acta 2005; 1733:101-110.
  • 6Sauer L, Nunes J, Salunkhe V, Skalska L, Kohama T, Cuvillier O, Waxman J, Pchejetski D. Sphingosine kinase 1 inhibition sensitizes hormone-resistant prostate cancer to docetaxel. Int J Cancer 2009; 125: 2728-2736.
  • 7Kapitonov D, Allegood JC, Mitchell C, Halt NC, Al-menara JA, Adams JK, Zipkin RE, Dent P, Kordula T, Milstien S, Spiegel S. Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts. Cancer Res 2009; 69:6915-6923.
  • 8Kyriakis JM, Avruch J. Mammalian mitogen-actirated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001; 81:807-869.
  • 9Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA. JAK/STAT, Raf/MEK/ ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 2004; 18:189-218.
  • 10McCubrey JA, Steelman LS, Abrams SL, Chappell WH, Russo S, Ove R, Milella M, Tafuri A, Lunghi P, Bonati A, Stivala F, Nicoletti F, Libra M, Martelli AM, Montalto G, Cervello M. Emerging MEK inhibitors. Expert Opin Emerg Drugs 2010; 15:203-223.

共引文献8

同被引文献86

  • 1姜大磊,高艳景,刘慧亚.SPK/S1P信号途径对人肝癌细胞VEGFmRNA表达的作用[J].山东大学学报(医学版),2009,47(9):73-75. 被引量:7
  • 2Lin Chen Tao Li Rong Li Bo Wei Zheng Peng.Alphastatin downregulates vascular endothelial cells sphingosine kinase activity and suppresses tumor growth in nude mice bearing human gastric cancer xenografts[J].World Journal of Gastroenterology,2006,12(26):4130-4136. 被引量:7
  • 3Saddoughi SA, Song P, Ogremen B. Roles of bioactive sphingo-lipids in cancer biology and therapeutics [ J ]. Subcell Biochem,2008,49: 413 -440.
  • 4Shida D, Takabe K, Kapitonov D, et al. Targeting SphKl as anew strategy against cancer[ J]. Curr Drug Targets,2008 ,9(8):662 -673.
  • 5Li W, Yu CP, Xia JT, et al. Sphingosine kinase 1 is associatedwith gastric cancer progression and poor survival of patients[ J].Clin Cancer Res, 2009,15(4) : 1393 -1399.
  • 6An GY,Baik YH,Choi MG’et al. The prognosis of gastric cardiacancer after R0 resection [ J]. Am J Surg, 2010,199 ( 6 ) : 725-729.
  • 7Bayerl MG, Bruqqeman RD, Conroy EJ,et al. Sphingosine ki-nase 1 protein and mRNA are overexpressed in non-Hodgkin lym-phomas and are attractive targets for novel pharmacological inter-ventions[ J]. Leuk Lymphoma, 2008 ,49(5) : 948 -954.
  • 8Facchinetti MM, Gandini NA, Femento ME, et al. The expres-sion of sphingosinnkinase-1 in head and neck carcinoma [ J ].Cells Tissues Organs, 2010,192(5) ; 314 -324.
  • 9Song L,Xiong H, Li J, et al. Sphingosine kinase-1 enhance re-sistance to apoptpsis through activation of PI3 K/Akt/NF-kBpathway in human non-smail cell lung cancer [ J ]. Clin CancerRes, 2011,17(7) : 1839 -1849.
  • 10Sun HY, Wei SP,Xu RC, et al. Sphingosine-1 -phosphate in-duces human endothelial VEGF and MMP-2 priductiong via tran-scription factor ZNF580: Novel insight into an angiogenesis [ J ].Biochem Biophys Res Commun,2010,395(3) : 361 -366.

引证文献8

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部